Welcome

Starting on June 27, all Drug Enforcement Administration (DEA)-registered practitioners will need to attest to 8 hours of CME dedicated to Opioid Use Disorder and/or Substance Use Disorder. This is a one-time attestation for all new and renewal applications. Past trainings do count towards the 8-hour requirement. If you previously held an X-Wavier or are boarded certified in addiction medicine, no further education is required for the DEA. Read more about the New DEA training requirement here. 

Please keep in mind for Illinois physician licensure (deadline July 31, 2023) there is a 3-hour opioid training requirement and for Wisconsin physician licensure (deadline October 31, 2023) there is a 2-hour opioid training requirement with renewals.

If you are looking for information on the upcoming Illinois Physician relicensure (in July 2023) requirements, visit this page: Illinois Licensure Requirements from IDFPR.

Requirements are subject to change, and each professional is responsible for ensuring that they are meeting the requirements for their licensure.

 

---> Looking to know what credits you have received so far through Advocate Aurora Health? Follow these instructions on How to print a certificate or a transcript <---

Advocate Health Resources

    Below is a list of current offerings from Advocate Health to help meet the DEA education requirements. New offerings will be added, so be sure to check back often.

      Online, recorded options:

      • Opioid Prescribing Procedure (1 hour): Opioid prescribing is still an issue across the country.  This course was developed by AAH to simplify guidelines to enable prescribing clinicians across AAH to closely monitor patients’ opioid use.
         
      • Opioid Weaning Procedure (30 minutes): This course covers the AAH recommendations for weaning patients from opioids: which patients should be weaned, the risks of weaning, and the newest clinical evidence for weaning procedure.
         
      • Drug Screening for Opioid Therapy (30 minutes): This course describes challenges in drug testing patients on opioid for chronic pain. We recommend specific tests, and discuss possible results and actions that may be taken based on those results. Advice for inconsistent drug screen results is also discussed.
         
      • Buprenorphine For Opioid Use Disorder (1 hour): This course will review of the use of buprenorphine for the treatment of opioid use disorder and discuss the barriers, challenges, risks, and efficacy of buprenorphine treatment.  Although evidence from numerous studies has shown buprenorphine to be effective for the treatment of opioid use disorder, a majority of patients with opioid use disorder do not receive buprenorphine, or any other medical treatment.
         
      • Emergency Department Buprenorphine Induction-EM (1 hour): This activity reviews the most recent opioid death statistics, includes patient with lived experiences videos, reviews induction of buprenorphine, the mechanism of buprenorphine and introduction of new containment xylazine. Dr. Coogan leads case scenarios to review common questions regarding buprenorphine.
         
      • Opioid Use Disorder PCP Case Conference (1 hour15-20 minute didactic session followed by real cases with discussion led by Dr. Diana Bottari, Addiction and Pain Medicine Physician.

      Point of Care:

      • UpToDate Search (available in Epic) - Point-of-care clinical resource for quick and concise information to support diagnosis and treatment decisions. Clinical topic overviews for adults and pediatrics, clinical calculators, patient education materials and drug information. Resource provided by Advocate Health: Health Information Technology (HIT). Register for a free UpToDate account while on an institutional network to get remote access, mobile app access, and CME credits. Visit this LibGuide for how to claim credit: UpToDate - Continuing Education - Library at Advocate Aurora Health (aah.org

      Other Resources

      Here are other resources available outside of Advocate Health to help meet the DEA education requirements: